Letter of Authorization - Stevanato Group
The LOA provides authorization to health authorities to review Ompi Master Files in parallel to the Marketing Authorization Holder (MAH) application.
Home - Managing Complexity, Delivering Value - Stevanato Group > About - Stevanato Group > Regulatory Support - Stevanato Group > Letter of Authorization - Stevanato Group
page-wrapper

Dear Customer,

Please fill out one (1) LOA request form for each drug product submission. The requested LOA(s) will be sent to you by e-mail. A LOA request needs to list only one targeted health authority.

The LOA provides authorization to health authorities to review Ompi Master Files in parallel to the Marketing Authorization Holder (MAH) application. Upon receiving your request, Ompi will proceed to provide you with LOA, by e-mail not later than four working days from the day of request, if otherwise not indicated or requested with urgency.

Once LOA is signed, DMF update and LOA will be forwarded to competent Regulatory Authority by 20 business days, if otherwise not requested. 

Note: * = Required fields

 

Stevanato group SpA and Nuova Ompi S.r.l. unipersonale owns several types of Master File submitted to US FDA and Health Canada;

 

Dossier type (number)

Products

US FDA


 

Type III (n° 011321)

Bulk: vials, syringes, cartridges, ampoules

Type III (n° 021723)

EZ-fill® vials and syringes  

Type III (n° 030397)

EZ-fill® cartridges

Type III (n° 033620)

EZ-fill® Alba® Products

Health Canada


 


 


 

Type II (n° MF 2003-095)

Bulk: vials, syringes, cartridges, ampoules

Type II (n° MF 2008-122)

EZ-fill® vials and syringes

Type II (n° MF 2024-081)

EZ-fill® Alba® Products

Type II (n° MF 2020-190)

EZ-fill® cartridges

 

Interested in Letter of Authorization?
Submit your request